• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有二肽基肽酶-4抑制作用的天然化合物:对糖尿病治疗的意义。

Natural compounds with DPP-4 inhibitory effects: Implications for the treatment of diabetes.

作者信息

Yaribeygi Habib, Atkin Stephen L, Sahebkar Amirhossein

机构信息

Chronic Kidney Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Weill Cornell Medicine Qatar, Doha, Qatar.

出版信息

J Cell Biochem. 2019 Jul;120(7):10909-10913. doi: 10.1002/jcb.28467. Epub 2019 Feb 18.

DOI:10.1002/jcb.28467
PMID:30775811
Abstract

Dipeptidyl peptidase-4 (DPP-4) inhibitors are antidiabetes agents that decrease blood glucose by preventing the degradation of endogenous glucagon-like peptide-1. The first DPP-4 was sitagliptin followed by several other agents in the class introduced to manage diabetes. Recent studies have suggested that naturally occurring compounds can exert an antidiabetes effect through DPP-4 inhibition. Such compounds may have a place in the treatment of diabetes within the diet; however, while DPP-4 inhibition alone is not associated with hypoglycemia, in combinations with other medication hypoglycemia can result, therefore, it is critical to know what herbal or food-based compounds may have these activities in the management of diabetes patients. In this review, we have outlined the compounds that have DPP-4 inhibition that may have utility in the treatment of diabetes.

摘要

二肽基肽酶-4(DPP-4)抑制剂是一类抗糖尿病药物,通过阻止内源性胰高血糖素样肽-1的降解来降低血糖。首个DPP-4抑制剂是西他列汀,随后该类又有其他几种药物被用于治疗糖尿病。最近的研究表明,天然存在的化合物可通过抑制DPP-4发挥抗糖尿病作用。这类化合物在糖尿病饮食治疗中可能占有一席之地;然而,虽然单独抑制DPP-4不会导致低血糖,但与其他药物联用时可能会引发低血糖,因此,了解哪些草药或食物类化合物在糖尿病患者管理中可能具有这些作用至关重要。在本综述中,我们概述了具有DPP-4抑制作用、可能对糖尿病治疗有用的化合物。

相似文献

1
Natural compounds with DPP-4 inhibitory effects: Implications for the treatment of diabetes.具有二肽基肽酶-4抑制作用的天然化合物:对糖尿病治疗的意义。
J Cell Biochem. 2019 Jul;120(7):10909-10913. doi: 10.1002/jcb.28467. Epub 2019 Feb 18.
2
Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes.用于糖尿病治疗的基于合成化合物和植物化合物的二肽基肽酶-IV(DPP-IV)抑制剂
J Asian Nat Prod Res. 2017 Oct;19(10):1036-1045. doi: 10.1080/10286020.2017.1307183. Epub 2017 Mar 29.
3
SODIUM GLUCOSE COTRANSPORTER 2 AND DIPEPTIDYL PEPTIDASE-4 INHIBITION: PROMISE OF A DYNAMIC DUO.钠-葡萄糖协同转运蛋白2与二肽基肽酶-4抑制作用:一对充满潜力的组合
Endocr Pract. 2017 Jul;23(7):831-840. doi: 10.4158/EP161725.RA. Epub 2017 Mar 23.
4
Dipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs.二肽基肽酶-4 抑制剂:多靶点药物,不仅仅是抗糖尿病药物。
J Diabetes. 2014 Jan;6(1):21-9. doi: 10.1111/1753-0407.12063. Epub 2013 Jun 19.
5
Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.二肽基肽酶-4的抑制作用:一种治疗2型糖尿病的新方法。
Curr Med Res Opin. 2007 Apr;23(4):919-31. doi: 10.1185/030079906x162746.
6
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.2型糖尿病患者口服葡萄糖耐量试验后,单剂量口服二肽基肽酶-4抑制剂西他列汀对肠促胰岛素和血糖水平的影响。
J Clin Endocrinol Metab. 2006 Nov;91(11):4612-9. doi: 10.1210/jc.2006-1009. Epub 2006 Aug 15.
7
Dipeptidyl peptidase-4 inhibitors: 3 years of experience.二肽基肽酶-4 抑制剂:3 年的经验。
Diabetes Technol Ther. 2012 Apr;14(4):350-64. doi: 10.1089/dia.2011.0204. Epub 2012 Feb 10.
8
Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo.新型二肽基肽酶-4抑制剂吉格列汀(LC15-0444)的体外和体内药理学特性
Eur J Pharmacol. 2016 Oct 5;788:54-64. doi: 10.1016/j.ejphar.2016.06.016. Epub 2016 Jun 11.
9
Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives.基于肠降血糖素的药物治疗 2 型糖尿病:关注东亚视角。
J Diabetes Investig. 2016 Apr;7 Suppl 1(Suppl 1):102-9. doi: 10.1111/jdi.12490. Epub 2016 Apr 18.
10
Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes.用于治疗2型糖尿病的二肽基肽酶-4抑制的药物化学方法。
Bioorg Med Chem. 2009 Mar 1;17(5):1783-802. doi: 10.1016/j.bmc.2009.01.061. Epub 2009 Jan 31.

引用本文的文献

1
In Vivo Regenerative Potential of in Pancreatic Tissue After Acute Stress with Chronic Consequences.急性应激后具有慢性后果的胰腺组织的体内再生潜力。
Molecules. 2025 May 22;30(11):2261. doi: 10.3390/molecules30112261.
2
A Novel Camel Milk-Derived Peptide LLPK Improves Glucose-Lipid Metabolism in / Mice via PPAR Signaling Pathway.一种新型骆驼奶衍生肽LLPK通过PPAR信号通路改善小鼠糖脂代谢。
Nutrients. 2025 May 16;17(10):1693. doi: 10.3390/nu17101693.
3
Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight.
与2型糖尿病相关的心血管代谢危险因素:机制洞察
Clin Med Insights Endocrinol Diabetes. 2023 Dec 25;16:11795514231220780. doi: 10.1177/11795514231220780. eCollection 2023.
4
Whey protein hydrolysates improve high-fat-diet-induced obesity by modulating the brain-peripheral axis of GLP-1 through inhibition of DPP-4 function in mice.乳清蛋白水解物通过抑制 DPP-4 功能调节 GLP-1 的脑-外周轴改善高脂肪饮食诱导的肥胖症。
Eur J Nutr. 2023 Sep;62(6):2489-2507. doi: 10.1007/s00394-023-03162-4. Epub 2023 May 8.
5
Biological and Therapeutic Effects of Troxerutin: Molecular Signaling Pathways Come into View.曲克芦丁的生物学及治疗作用:分子信号通路渐趋明晰。
J Pharmacopuncture. 2021 Mar 31;24(1):1-13. doi: 10.3831/KPI.2021.24.1.1.
6
Effects of 22 traditional anti-diabetic medicinal plants on DPP-IV enzyme activity and glucose homeostasis in high-fat fed obese diabetic rats.22 种传统抗糖尿病药用植物对高脂肪喂养肥胖型糖尿病大鼠 DPP-IV 酶活性和葡萄糖稳态的影响。
Biosci Rep. 2021 Jan 29;41(1). doi: 10.1042/BSR20203824.
7
In Vivo Studies of Inoculated Plants and In Vitro Studies Utilizing Methanolic Extracts of Endophytic sp. Strain DBT34 Obtained from L. Exhibit ROS-Scavenging and Other Bioactive Properties.从 L. 中获得的内生菌 sp. 菌株 DBT34 的接种植物的体内研究和利用其甲醇提取物的体外研究显示出清除活性氧和其他生物活性特性。
Int J Mol Sci. 2020 Oct 6;21(19):7364. doi: 10.3390/ijms21197364.